Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis. - Wikidata - wikimedia - TriplyDB

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.

http://www.wikidata.org/entity/Q35121804

about

Integrated therapy for HIV and tuberculosis HIV and tuberculosis--science and implementation to turn the tide and reduce deaths Diagnosis & treatment of tuberculosis in HIV co-infected patients.Six months therapy for tuberculous meningitis Early versus Delayed Antiretroviral Therapy for HIV and Tuberculosis Co-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults.Lymphoma immune reconstitution inflammatory syndrome in the center for AIDS research network of integrated clinical systems cohort Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis Tuberculosis in children.Update on opportunistic infections in the era of effective antiretroviral therapy Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial.Evolution of HIV treatment guidelines in high- and low-income countries: converging recommendations New insights into immune reconstitution inflammatory syndrome of the central nervous system.Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review.The impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: a systematic review and meta-analysis.Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction.Healthcare provision for HIV co-infected tuberculosis patients in rural Zambia: an observational cohort study at primary care centers.Immune reconstitution inflammatory syndrome in HIV-infected patients Antiretroviral therapy: when to start Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand.Tuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipients Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial.The Effect of Early Initiation of Antiretroviral Therapy in TB/HIV-Coinfected Patients: A Systematic Review and Meta-Analysis.Tuberculous meningitis: diagnosis and treatment overview.Impact of HIV on mortality among patients treated for tuberculosis in Lima, Peru: a prospective cohort study Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis.Tuberculosis drug development: ensuring people living with HIV are not left behind.Influence of antituberculosis drug resistance and Mycobacterium tuberculosis lineage on outcome in HIV-associated tuberculous meningitis.Clinical presentations, diagnosis, mortality and prognostic markers of tuberculous meningitis in Vietnamese children: a prospective descriptive study.Causes of mortality among tuberculosis and HIV co-infected patients in Chiang Rai, Northern Thailand.Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia.Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none.Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome.Improved diagnostic sensitivity for tuberculous meningitis with Xpert(®) MTB/RIF of centrifuged CSF.When to start antiretroviral therapy during tuberculosis treatment?Tuberculous meningitis: presentation, diagnosis and outcome in hiv-infected patients at the douala general hospital, cameroon: a cross sectional study Antiretroviral therapy initiation during tuberculosis treatment and HIV-RNA and CD4 T-lymphocyte responses.Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment

P2860

Q26749428-D3F14307-414D-4C96-B43B-C0713D1139D9 Q26824501-7896D4BA-9B2C-4200-A1F8-811939387344 Q26991633-E3B5E843-A730-4282-A775-68E5EF98A489 Q28074247-901F50C7-ED18-4D86-9052-10226BEA0DEB Q28547436-39ABA5F1-B640-4CB6-89E2-73349EBBAB41 Q33775397-B53991C4-F565-4503-B4AA-867F8C96FA0F Q33917964-29ABC6F2-34F3-4029-BEE3-5FF868479138 Q34024416-286F6C9E-7CF5-4F9B-9C24-77A0D3202D3E Q34063630-80E86AE3-530E-4DE2-8010-F12B60316921 Q34083196-C263A8CA-D2E5-4B83-BED9-652E95944851 Q34085853-C36F5B48-6D17-4B27-9CEA-F40AFCD9F5A6 Q34137755-EEFDA7E4-0159-4231-AF76-048A9C6C41CF Q34321843-707230FE-6E33-4EB5-BCF5-F616FDF05985 Q34433828-10DC7E4B-B2C5-42EE-9871-453E628D2E29 Q34455442-1EC89CA7-2209-4D45-A1F0-C020914828F6 Q34497528-80157F22-B742-4D12-8503-0D954EF2FDE7 Q34730629-74EC502C-F04B-492F-B762-5D22C39E2341 Q35011024-4FC97495-98EB-4B8A-BFF6-608D3B9DBE7D Q35100818-58EF1740-3A3A-49DE-ADB3-B651B7E6BC6C Q35204279-3E5E4A21-5DD0-4216-B23B-F52FA8760178 Q35530299-C343188C-12E7-4EB9-8BB8-E454D9BA5B4C Q35557036-A759E9B2-13A5-46EB-A066-475936C0102A Q35598520-673713CD-7B7D-423E-9AE2-852D8E85A822 Q35750657-C99F2AC8-D1C4-4921-BC16-0CAB8F0A84C0 Q35910242-7EFAD96A-62FA-4453-931F-3E87A7AB6892 Q35910430-B663F28B-C9E4-4DAE-A4EB-2A480D5A1DE4 Q35919786-AC1655EE-D359-4253-B31D-FE0043898BE9 Q35991204-4ED806C3-CBDB-4E7A-9CB1-048E8C263F2E Q36018701-6F9F207A-0E9A-4805-BCEC-D23AFD07364D Q36166714-5D9378A3-6330-495A-BEF9-66D2A2197A3E Q36311260-667162C1-EB17-483E-9EF0-DC21C10E7257 Q36349886-FD3B84A6-496F-4559-9D81-154219DE0EF5 Q36426562-EB594E0B-9665-40B1-BE29-E122A70BCD4C Q36458503-C5422408-CBCC-4891-812D-D5D29AA358A2 Q36517790-88DB65DF-B45D-40D1-8043-E02260F4BB78 Q36622358-54C179EC-BB7C-4DC2-85C0-B554C079ECF0 Q36739450-5B5D29F0-2A42-46D0-93AA-653FA1CE6E5E Q36940677-C935641B-BCF1-47D2-ADB2-739B1473088C Q37056172-8D60DB10-4446-41E5-BDC8-C2C75EE96BCE Q37103666-C4EBCE13-BC54-4DDF-85F1-070429F89CFF

P2860

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.

http://www.wikidata.org/entity/Q35121804

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Timing of initiation of antire ...... ciated tuberculous meningitis.

@ast

Timing of initiation of antire ...... ciated tuberculous meningitis.

@en

type

label

Timing of initiation of antire ...... ciated tuberculous meningitis.

@ast

Timing of initiation of antire ...... ciated tuberculous meningitis.

@en

prefLabel

Timing of initiation of antire ...... ciated tuberculous meningitis.

@ast

Timing of initiation of antire ...... ciated tuberculous meningitis.

@en

P1433

Q35121804-1DC7F9C5-6B2C-42CA-9F24-7F71FBD89C71

P1476

Q35121804-C90ED0CB-927E-4868-8098-C632C8ED7FE6

P2093

Q35121804-0E9A64C3-221D-4999-AC47-A8DF417091CD

Q35121804-1A033235-C06B-4AD1-A578-15B0F894212F

Q35121804-1EEC0BC9-51D1-4658-B501-8501C7E22FD7

Q35121804-32E8D620-CCD5-4234-83BA-93A940A31559

Q35121804-3A38ECA6-2F30-4703-A0A1-7F16ECBD1D18

Q35121804-3AB6F7A5-5FF1-4E3D-9EAB-3456A6D4B208

Q35121804-41468A49-1DD6-4D8A-BFE7-4233CE717738

Q35121804-4BDC0F6C-DF85-4EFC-AA21-102BA024865F

Q35121804-5003135A-5790-4362-A8E0-61BD68D85AB0

Q35121804-62BAAD2E-F1F6-4E24-AFB3-2AF55FCCB78D

P2860

Q35121804-0F02AB74-C9F9-4331-A0FE-33C6C8A9E06E

Q35121804-2013D72B-F20A-4843-B8E6-1BBB42456197

Q35121804-33A6FB3D-AFB3-4AF1-98D6-301BDE7199CB

Q35121804-61DCD5DF-3B49-4A23-877C-63CD79C59532

Q35121804-6C894F64-69A8-4C9C-8D53-0911BFBDA348

Q35121804-76E00A42-B252-4636-92CD-93687B12DF3D

Q35121804-9EA3A744-EEAD-4AD2-A899-ECCE21337DF1

Q35121804-A4387C63-5142-4A4A-8053-84CC9A283663

Q35121804-B2688F5A-A407-4780-95EF-CDC34E0A9350

Q35121804-B50047EB-7F7E-4A61-A5D5-81B0CAA068A4

P304

Q35121804-BADB0716-54C1-425D-80D3-E46A56D708F3

P31

Q35121804-D676D3A8-1355-4EC4-80B1-A867AF9373AD

P356

Q35121804-5EF8F259-879A-4225-B242-B41C54302A80

P407

Q35121804-D4B85CEE-3E05-4759-8FD8-A123962D72B7

P433

Q35121804-4192B9A7-7B90-4FF0-8261-629AEA017BE4

P478

Q35121804-666E3A85-7986-4401-90B6-FAB8B94A600F

P50

Q35121804-0CE1153F-5250-4BA8-A9A8-5869A4BEEA27

Q35121804-37E75A3A-E454-4490-9747-2EB0F2813B3E

Q35121804-3DE87F0A-F2A7-4CF6-99EE-6CAB40192726

Q35121804-5A027480-A463-4284-A30C-E1242B1A71EC

Q35121804-6A129C9E-2754-4515-B84E-1FA224050ED6

Q35121804-DDD49B5A-58EC-4AAA-829E-753E46AD51F6

P577

Q35121804-CF55A7E5-1AE4-4B8D-BF49-4EAF5E591F22

P5875

Q35121804-AF4B3F05-DE63-4616-9D14-E3BB362F1BC3

P698

Q35121804-21268156-AAF1-40F6-B361-9B768052A1F7

P921

Q35121804-53F23FBC-F12B-473A-93A1-AAA40F311C4F

Q35121804-E4AE1DC8-00CE-40B7-90A7-B77AFA57FBA0

P932

Q35121804-FD0FBE83-792E-4DE1-B1E4-E3FA8FEF31A0

P356

P1433

Clinical Infectious Diseases

P1476

Timing of initiation of antire ...... ciated tuberculous meningitis.

@en

P2093

Do Thi Tuong Anh

http://www.w3.org/2001/XMLSchema#string

Doan The Dong

http://www.w3.org/2001/XMLSchema#string

Hoang Thi Quy

http://www.w3.org/2001/XMLSchema#string

M Estee Török

http://www.w3.org/2001/XMLSchema#string

Menno de Jong

http://www.w3.org/2001/XMLSchema#string

N H Minh

http://www.w3.org/2001/XMLSchema#string

Nguyen Anh Tien

http://www.w3.org/2001/XMLSchema#string

Nguyen Duc Bang

http://www.w3.org/2001/XMLSchema#string

Nguyen Hoan Phu

http://www.w3.org/2001/XMLSchema#string

Nguyen Huy Dung

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults

Worst-rank score analysis with informatively missing observations in clinical trials.

Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults.

Timing of initiation of antiretroviral drugs during tuberculosis therapy.

Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.

Tuberculous meningitis in patients with and without human immunodeficiency virus infection.

Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials.

Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.

Tuberculous meningitis among adults with and without HIV infection. Experience in an urban public hospital.

The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis.

P304

1374-1383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIR230

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

Nguyen Van Vinh Chau

Cameron P. Simmons

Tran Thi Hong Chau

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51150530

http://www.w3.org/2001/XMLSchema#string

P698

21596680

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

4340579

http://www.w3.org/2001/XMLSchema#string